Literature DB >> 21095314

The use of human acellular dermal matrix for chest wall reconstruction.

Phillip S Ge1, Taryne A Imai, Armen Aboulian, Timothy L Van Natta.   

Abstract

BACKGROUND: Reconstruction of chest wall defects has evolved, but challenges remain. This is particularly true when defects are large or contamination is present. Although numerous materials are available for reconstruction, acellular dermal matrix has the advantage of becoming vascularized and incorporated autologously. By its resistance to infection and lack of adhesion formation, it is a promising although expensive alternative to synthetic materials in some circumstances. This report examines our experience with human acellular dermal matrix (HADM) in reconstruction of major chest wall and diaphragmatic defects.
METHODS: A retrospective study was conducted of all patients who underwent thoracic reconstruction using HADM between March 2007 and March 2010 at Harbor-University of California-Los Angeles Medical Center. Data acquisition included demographics, surgical indications, operative details, complications, and follow-up evaluation.
RESULTS: Ten patients were identified. Indications included thoracic tumor resection in 5, Clagett procedure modification for postpneumonectomy empyema in 2, resection of chest wall osteomyelitis in 2, and pneumonectomy for multiple aspergillomata in 1. Complications occurred in 4 patients and included respiratory failure, pneumonia, and wound seromas. All wounds healed without need to remove or revise the HADM, and sound chest wall closure was achieved in every case.
CONCLUSIONS: HADM is an effective but expensive alternative to synthetic mesh in reconstruction of chest wall and diaphragmatic defects. It is particularly attractive for use under conditions of potential or overt contamination.
Copyright © 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21095314     DOI: 10.1016/j.athoracsur.2010.07.080

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Application of xenogenic acellular dermal matrix in reconstruction of oncological hypopharyngeal defects.

Authors:  Ping Li; Shisheng Li; Xinming Yang; Qinglai Tang; Xiangbo He; Shuang Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-10       Impact factor: 2.503

2.  Properties of novel composite meshes in chest wall reconstruction: A comparative animal study.

Authors:  Patrick Zardo; Ruoyu Zhang; Stefan Freermann; Stefan Fischer
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

3.  Acellular dermal matrix and bone cement sandwich technique for chest wall reconstruction.

Authors:  Chan Yeong Heo; Byungkwon Kang; Jae Hoon Jeong; Kwhanmien Kim; Yujin Myung
Journal:  Arch Plast Surg       Date:  2022-01-15

4.  The Use of Acellular Dermal Matrix (Integra Single Layer) for the Correction of Malformative Chest Wall Deformities: First Case Series Reported.

Authors:  Carlos Delgado-Miguel; Miriam Miguel-Ferrero; Antonio Muñoz-Serrano; Mercedes Díaz; Juan Carlos López-Gutiérrez; Carlos De la Torre
Journal:  Surg J (N Y)       Date:  2022-08-16

5.  Chest wall and diaphragm reconstruction; a technique not well established in literature - case report.

Authors:  Riad Abdel Jalil; Mohamad K Abou Chaar; Obada Al-Qudah; Hanna Kakish; Salam Elfar
Journal:  J Cardiothorac Surg       Date:  2021-07-09       Impact factor: 1.637

6.  Thoracic wall reconstruction with Collamend® in trauma: report of a case and review of the literature.

Authors:  Federico Coccolini; Marco Lotti; Paolo Bertoli; Roberto Manfredi; Dario Piazzalunga; Stefano Magnone; Luca Campanati; Luca Ansaloni
Journal:  World J Emerg Surg       Date:  2012-12-23       Impact factor: 5.469

7.  The use of synthetic mesh in reconstructive, revision, and cosmetic breast surgery.

Authors:  Hilton Becker; Jeffrey G Lind
Journal:  Aesthetic Plast Surg       Date:  2013-07-17       Impact factor: 2.326

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.